A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer
Phase 1
Recruiting
- Conditions
- Colorectal Cancer Metastatic
- First Posted Date
- 2023-03-08
- Last Posted Date
- 2024-03-19
- Lead Sponsor
- Carina Biotech Limited
- Target Recruit Count
- 45
- Registration Number
- NCT05759728
- Locations
- 🇦🇺
Carina Biotech Investigators, Adelaide, South Australia, Australia
© Copyright 2025. All Rights Reserved by MedPath